Your browser doesn't support javascript.
loading
Infectious and immunological sequelae of daratumumab in multiple myeloma.
Johnsrud, Andrew J; Johnsrud, Joyce J; Susanibar, Sandra A; Kamimoto, Jorge J; Kothari, Atul; Burgess, Mary; Van Rhee, Frits; Rico, Juan C.
Afiliação
  • Johnsrud AJ; Department of Hematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Johnsrud JJ; Division of Infectious Diseases, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Susanibar SA; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Kamimoto JJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Kothari A; Division of Infectious Diseases, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Burgess M; Division of Infectious Diseases, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Van Rhee F; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Rico JC; Division of Infectious Diseases, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Br J Haematol ; 185(1): 187-189, 2019 04.
Article em En | MEDLINE | ID: mdl-29974956
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunomodulação / Antineoplásicos Imunológicos / Infecções / Anticorpos Monoclonais / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunomodulação / Antineoplásicos Imunológicos / Infecções / Anticorpos Monoclonais / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article